Diagnostic Testing for Diabetes Insipidus.
Gubbi S, Hannah-Shmouni F, Koch CA, Verbalis JG.
2022 Nov 28. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–.
Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial.
Atila C, Holze F, Murugesu R, Rommers N, Hutter N, Varghese N, Sailer CO, Eckert A, Heinrichs M, Liechti ME, Christ-Crain M.
Lancet Diabetes Endocrinol. 2023 Jul;11(7):454-464. doi: 10.1016/S2213-8587(23)00120-1. Epub 2023 May 13.
Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study.
Winzeler B, Cesana-Nigro N, Refardt J, Vogt DR, Imber C, Morin B, Popovic M, Steinmetz M, Sailer CO, Szinnai G, Chifu I, Fassnacht M, Christ-Crain M.
Lancet. 2019 Aug 17;394(10198):587-595. doi: 10.1016/S0140-6736(19)31255-3. Epub 2019 Jul 11.
ADIPSIC DIABETES INSIPIDUS: A REVIEW.
Eisenberg Y, Frohman LA.
Endocr Pract. 2016 Jan;22(1):76-83. doi: 10.4158/EP15940.RA. Epub 2015 Sep 24.
Genetic forms of neurohypophyseal diabetes insipidus.
Spiess M, Beuret N, Rutishauser J.
Best Pract Res Clin Endocrinol Metab. 2020 Sep;34(5):101432. doi: 10.1016/j.beem.2020.101432. Epub 2020 Jun 19.
Central diabetes insipidus and partial anterior pituitary dysfunction in acute myeloid leukemia.
Arya R, Ahmad T, Dash S.
Endocrinol Diabetes Metab Case Rep. 2022 Jul 1;2022:21-0153. doi: 10.1530/EDM-21-0153. Online ahead of print.
Management of Hypopituitarism.
Alexandraki KI, Grossman A.
J Clin Med. 2019 Dec 5;8(12):2153. doi: 10.3390/jcm8122153.
Oxcarbazepine Therapy for Complete Central Diabetes Insipidus.
Abdallah B, Hodgins S, Landry D, O'shea M, Braden G.
Case Rep Nephrol Dial. 2018 Jan 31;8(1):20-24. doi: 10.1159/000485244. eCollection 2018 Jan-Apr.
Central Diabetes Insipidus: An Acute Manifestation of COVID-19 Infection.
Suresh Kumar S, Kumar K, Venkataramani S, Ghazi NM.
Cureus. 2023 Aug 21;15(8):e43884. doi: 10.7759/cureus.43884. eCollection 2023 Aug.
Genetic forms of neurohypophyseal diabetes insipidus.
Rutishauser J, Spiess M, Kopp P.
Best Pract Res Clin Endocrinol Metab. 2016 Mar;30(2):249-62. doi: 10.1016/j.beem.2016.02.008. Epub 2016 Feb 18.
